4.7 Review

Exploring the Potential of Aptamers in Targeting Neuroinflammation and Neurodegenerative Disorders: Opportunities and Challenges

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Anti-Neuroinflammatory Potential of Natural Products in the Treatment of Alzheimer's Disease

Mingzhenlong Deng et al.

Summary: Alzheimer's disease is the main cause of dementia in the elderly and is caused by multiple factors, with aging and neuroinflammation being the main factors. While there is currently no cure for Alzheimer's disease, the relationship between neuroinflammation and the disease may provide a new strategy for treatment. Natural anti-inflammatory products, such as alkaloids, steroids, terpenoids, flavonoids, and polyphenols, show potential in preventing and alleviating symptoms of Alzheimer's disease, and can be developed into anti-AD drugs.

MOLECULES (2023)

Review Cell Biology

Targeting neuroinflammation in Alzheimer's disease: from mechanisms to clinical applications

Zi-Zhen Si et al.

Summary: Alzheimer's disease is characterized by sustained neuroinflammation leading to memory loss and cognitive decline. Efforts have been made to understand its pathogenesis, but effective treatment is still lacking. Neuroinflammation, along with misfolded and aggregated proteins, plays a significant role in the disease. The review summarizes the clinical and pathological characteristics, discusses the role of glial cells, and explores potential therapeutic approaches in targeting neuroinflammation.

NEURAL REGENERATION RESEARCH (2023)

Article Chemistry, Analytical

Detection of ?-amyloid peptide aggregates by quartz crystal microbalance based on dual-aptamer assisted signal amplification

Chenchen Wang et al.

Summary: In this study, a dual-aptamer assisted A beta 40 aggregates assay was developed using quartz crystal microbalance. The assay can detect both A beta 40O and A beta 40F, and it is simple and highly sensitive.

ANALYTICA CHIMICA ACTA (2023)

Article Biochemistry & Molecular Biology

Structurally Different Yet Functionally Similar: Aptamers Specific for the Ebola Virus Soluble Glycoprotein and GP1,2 and Their Application in Electrochemical Sensing

Soma Banerjee et al.

Summary: The Ebola virus glycoprotein (GP) gene produces several mRNAs that generate different proteins, including a transmembrane protein and two secreted glycoproteins. Three structurally distinct aptamers were selected to bind with the secreted glycoprotein (sGP) and the transmembrane protein (GP1,2). These aptamers showed high affinity and selectivity for sGP and GP1,2 and could detect them with high sensitivity in the presence of serum.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Chemistry, Multidisciplinary

Aptamer-Based Targeted Delivery of Functional Nucleic Acids

Sitao Xie et al.

Summary: Functional nucleic acid (NA)-based drugs have a wide range of applications in altering and controlling gene/protein expression patterns in cells. However, the precise delivery of functional NA to specific cells/organs is challenging due to the difficulty in crossing cell membranes and avoiding adverse effects on non-targeted cells. Aptamers, with their high specificity and selectivity for cell surface proteins, can be used as molecular recognition units for accurately binding target cells and enabling efficient cargo delivery. This perspective summarizes original aptamer-based strategies for targeted delivery of functional NA and discusses challenges and opportunities in this field.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2023)

Review Neurosciences

Intracellular DAMPs in Neurodegeneration and Their Role in Clinical Therapeutics

Jasleen Kaur et al.

Summary: Neuroinflammation, triggered by cellular injury and the innate immune system, is a critical factor in neurodegenerative diseases. Damage-associated molecular patterns (DAMPs) are endogenous danger indicators released from different compartments of cells under pathological stimulation, and they play a significant role in the inflammatory cascade and cytokine release. This review focuses on DAMP molecules originating from intracellular compartments and their roles in neurodegenerative events, including downstream mediators and signaling pathways. Additionally, recent interventions involving DAMPs as clinical biomarkers for disease detection and targeting the innate immune activation response to reduce sterile neuroinflammation are discussed.

MOLECULAR NEUROBIOLOGY (2023)

Review Pharmacology & Pharmacy

Advances in the mechanisms and applications of inhibitory oligodeoxynucleotides against immune-mediated inflammatory diseases

Hongrui Wang et al.

Summary: Inhibitory oligodeoxynucleotides (ODNs) are short DNA strands capable of binding to various targets. They have potential therapeutic applications in immune-mediated inflammatory diseases (IMIDs) due to their immunomodulatory activity. Inhibitory ODNs can target RNAs or proteins, reducing or increasing protein expression and regulating the immune activation state. They have also been used to treat inflammatory disorders and autoimmune diseases, with several drugs already approved on the market. This review discusses the chemical modifications, action mechanisms, and applications of inhibitory ODNs in the precise treatment of IMIDs.

FRONTIERS IN PHARMACOLOGY (2023)

Article Clinical Neurology

APRIL: A double-blind, placebo-controlled, randomized, Phase Ib/IIa clinical study of ApTOLL for the treatment of acute ischemic stroke

Macarena Hernandez-Jimenez et al.

Summary: In the reperfusion era, the combination of endovascular treatment (EVT) and neuroprotective drugs, such as ApTOLL, is emerging as a promising therapeutic option for patients with acute ischemic stroke (AIS). ApTOLL, a Toll-like receptor 4 (TLR4) antagonist, has shown neuroprotective effects in preclinical models and has a favorable pharmacokinetic and safety profile. This clinical trial, called APRIL, aims to assess the tolerability, safety, pharmacokinetics, and biological effect of ApTOLL in AIS patients eligible for EVT.

FRONTIERS IN NEUROLOGY (2023)

Article Chemistry, Analytical

Development of an Aptamer-Based Molecular Tool for Specifically Targeting Microglia via the CD64 Protein

Hui Zhu et al.

Summary: In this study, a high-affinity DNA aptamer, ZH-1c, was developed to target activated inflammatory microglia. It exhibited promising binding ability under physiological temperatures, high serum stability, and internalization by microglia. The target of ZH-1c on microglia was identified as the transmembrane protein CD64, which increased in response to inflammatory stimulation, enhancing the affinity of ZH-1c for activated microglia. Overall, ZH-1c shows great potential as a novel and effective molecular tool for the diagnosis and microglia-targeted therapies.

ANALYTICAL CHEMISTRY (2023)

Article Engineering, Biomedical

Targeted immunotherapy of triple-negative breast cancer by aptamer-engineered NK cells

Zhenghu Chen et al.

Summary: This study demonstrates a novel immunotherapeutic approach for targeting triple-negative breast cancer (TNBC) using aptamer-engineered NK cells. The synthetic aptamer probes selectively target TNBC cell lines and trigger apoptosis and death of cultured TNBC cells. Systemic administration of aptamer-engineered NK cells inhibits lung metastasis in mice harboring TNBC xenografts.

BIOMATERIALS (2022)

Article Pharmacology & Pharmacy

The natural (poly)phenols as modulators of microglia polarization via TLR4/NF-κB pathway exert anti-inflammatory activity in ischemic stroke

Ruoqi Li et al.

Summary: This article discusses the role of inflammation in stroke and the therapeutic approach of modulating microglial phenotypes through the TLR4/NF-kappa B signaling pathway. It is found that dietary (poly)phenols have anti-inflammatory properties and provide protective effects on ischemic stroke.

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

Review Biochemistry & Molecular Biology

Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases

Kazuma Murakami et al.

Summary: Aptamers, similar to antibodies, are oligonucleotides selected based on their affinity for bioactive molecules. They have advantages such as small size, easy synthesis, high stability, and low immunogenicity. However, developing aptamers against amyloidogenic proteins, which are relevant to neurodegenerative diseases, is challenging due to their conformational instability and heterogeneity. Recent advancements in chemical tethering of aptagens, high-throughput sequencing-based analysis, and internalization technologies have helped overcome some of these challenges. This review highlights the preclinical application of antiamyloid aptamers to central nervous system therapy.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Review Biochemistry & Molecular Biology

Aptamers: Potential Diagnostic and Therapeutic Agents for Blood Diseases

Maher M. Aljohani et al.

Summary: Aptamers are RNA/DNA oligonucleotide molecules that specifically bind to targeted molecules. They have potential diagnostic and therapeutic applications for blood diseases and offer advantages over antibodies in terms of selection, production, modification, stability, and immunogenicity. Several aptamers have been developed and investigated in various biomedical areas. The pegaptanib sodium injection, an aptamer-based therapeutic, has been approved by the FDA for therapeutic use. Other aptamers are also in clinical trials. This review highlights the current status and promising aptamers in pre-clinical development for blood diseases.

MOLECULES (2022)

Article Multidisciplinary Sciences

LPS-induced lipid alterations in microglia revealed by MALDI mass spectrometry-based cell fingerprinting in neuroinflammation studies

Martina Blank et al.

Summary: This study used matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) to investigate the lipid patterns in activated microglial cells. The results showed significant differences in lipid profiles between lipopolysaccharide (LPS)-stimulated and unstimulated cells, leading to the identification of 21 potential inflammation-associated lipid markers. Additionally, treatment with a histone deacetylase inhibitor reduced the inflammation response in LPS-stimulated microglial cells.

SCIENTIFIC REPORTS (2022)

Article Cell Biology

Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function

Md Masud Alam et al.

Summary: Recent studies have shown that alpha-synuclein plays a crucial role in normal vertebrate physiology and is a critical mediator of inflammatory and immune responses. Neural cells are the sources of alpha-synuclein required for immune competence.

CELL REPORTS (2022)

Review Geriatrics & Gerontology

Microglia Polarization From M1 to M2 in Neurodegenerative Diseases

Shenrui Guo et al.

Summary: Microglia-mediated neuroinflammation is a common feature of neurodegenerative diseases, and microglia can be categorized into M1 and M2 types with opposite functions. Modulating microglia M1/M2 polarization shows promising therapeutic potential in neurodegenerative diseases.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Article Biochemistry & Molecular Biology

NXP032 Ameliorates Aging-Induced Oxidative Stress and Cognitive Impairment in Mice through Activation of Nrf2 Signaling

Jae-Min Lee et al.

Summary: Aging is a neurodegenerative disease that leads to cognitive impairment, primarily due to increased oxidative stress. We developed NXP032, a complex of vitamin C and DNA aptamer, to enhance the antioxidant effectiveness of vitamin C. In a study on female mice, NXP032 administration alleviated cognitive impairment, neuronal damage, microglia activity, and oxidative stress caused by aging. NXP032 also activated the Nrf2-ARE pathway, suggesting its potential as a therapeutic intervention for aging-induced cognitive impairment and oxidative stress.

ANTIOXIDANTS (2022)

Article Plant Sciences

Natural Products as Novel Neuroprotective Agents; Computational Predictions of the Molecular Targets, ADME Properties, and Safety Profile

Sahar Saleh Alghamdi et al.

Summary: Neurodegenerative diseases pose a significant challenge to public health, and effective treatments are still lacking. Natural products targeting microglia have shown promise in the prevention and treatment of these diseases, but concerns about their usage persist due to a lack of scientific evidence regarding their efficacy, targets, properties, and safety. In this study, secondary bioactive metabolites from neuroprotective medicinal plants were computationally predicted and evaluated for anti-inflammatory activity, targets, properties, and safety. Promising compounds such as Aromatic-turmerone, Apocynin, and Matrine were identified for their potential in modulating microglial polarization and treating neurodegenerative diseases.

PLANTS-BASEL (2022)

Article Chemistry, Medicinal

Cytokines in the Brain and Neuroinflammation: We Didn't Starve the Fire!

Jan Pieter Konsman

Summary: Despite the protective tissues and barriers in the brain, certain injuries or infections can lead to changes in brain function and behavior due to cytokine production and action. Peripheral infection-induced inflammation and psychological stress may also have similar effects on the central nervous system. Understanding the conditions of cytokine production and action in the brain is important for studying neuroinflammation and exploring ways to modify neural functioning.

PHARMACEUTICALS (2022)

Article Cell Biology

Amyloid-β activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk-AMPK pathway

Eun Sun Jung et al.

Summary: The study reveals that amyloid-beta activates the NLRP3 inflammasome in microglia by activating Syk and inhibiting AMPK, leading to neuroinflammation. Additionally, flufenamic acid (FA), a non-steroidal anti-inflammatory drug, effectively inhibits microglial activation of the NLRP3 inflammasome by regulating Syk and AMPK, offering a potential treatment for AD.

AGING CELL (2022)

Review Pharmacology & Pharmacy

Special Section on Pharmacokinetics and ADME of Biological Therapeutics-Minireview Absorption, Distribution, Metabolism, and Excretion of US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs

Julia M. Migliorati et al.

Summary: Absorption, distribution, metabolism, and excretion (ADME) are key biological processes that determine a drug's pharmacokinetic parameters and directly impact its efficacy and adverse reactions. This review focuses on the unique ADME characteristics of antisense oligonucleotide (ASO) drugs, which have diverse modes of drug actions and great potential for treating diseases untreatable by small molecule-based drugs. A meta-analysis of 10 FDA-approved ASO drugs provides comprehensive insights into their formulation, dosage, administration sites, distribution, metabolism, and excretion, improving our understanding of their therapeutic efficacy and potential adverse reactions.

DRUG METABOLISM AND DISPOSITION (2022)

Review Biochemistry & Molecular Biology

Research progress of whole-cell-SELEX selection and the application of cell-targeting aptamer

Yu Duan et al.

Summary: Whole-cell SELEX (WC-SELEX), as a novel method for screening aptamers, has gained increasing attention in various fields. However, traditional WC-SELEX suffers from long experimental period, complicated operation process and low specificity. Therefore, more efficient screening methods are being developed.

MOLECULAR BIOLOGY REPORTS (2022)

Article Clinical Neurology

Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II

Jutta Gaertner et al.

Summary: The study showed that ofatumumab is more effective and safer than teriflunomide in recently diagnosed, treatment-naive patients with relapsing multiple sclerosis. Compared with teriflunomide, ofatumumab significantly reduced the annualized relapse rate, delayed confirmed disability worsening, and delayed progression independent of relapse activity.

MULTIPLE SCLEROSIS JOURNAL (2022)

Review Pharmacology & Pharmacy

Targeting complement in neurodegeneration: challenges, risks, and strategies

Wioleta M. Zelek et al.

Summary: This article summarizes the role of complement in neurodegenerative diseases and makes a case for testing anti-complement drugs. It also discusses how drugs can be modified or designed to inhibit complement in neurodegeneration.

TRENDS IN PHARMACOLOGICAL SCIENCES (2022)

Article Biochemistry & Molecular Biology

Aptamers Targeting Hallmark Proteins of Neurodegeneration

Niloufar Mollasalehi et al.

Summary: Neurodegenerative diseases (NDs) are characterized by progressive deterioration of neural structures, leading to cognitive or motor impairment. Effective therapies for common NDs such as Alzheimer's or Parkinson's disease are still lacking. This study explores the development of aptamers for targeting proteins associated with NDs and their potential applications in imaging, protein detection, and quantification, accelerating their clinical use for diagnosis and therapy.

NUCLEIC ACID THERAPEUTICS (2022)

Review Neurosciences

General Principles Underpinning Amyloid Structure

Alexander I. P. Taylor et al.

Summary: Amyloid fibrils are a relevant state of protein folding that differs from globular proteins in terms of symmetry, conformational order, and supramolecular scale. Recent advancements in techniques have provided a wealth of information about the molecular and supramolecular organization of amyloids, allowing for a unified understanding of their formation and unique properties.

FRONTIERS IN NEUROSCIENCE (2022)

Article Medicine, Research & Experimental

The Aptamer Ob2, a novel AChE inhibitor, restores cognitive deficits and alleviates amyloidogenesis in 5xFAD transgenic mice

Zhiman Liang et al.

Summary: In this study, the DNA aptamer Ob2 showed effective inhibition of AChE activity and improved cognitive ability in a mouse model of AD. The mechanism of action may involve inhibition of AChE activity, reduction of A beta expression through lowering BACE1 levels, and activation of astrocytes.

MOLECULAR THERAPY-NUCLEIC ACIDS (2022)

Article Medicine, Research & Experimental

First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers

Macarena Hernandez-Jimenez et al.

Summary: This study characterized the safety and pharmacokinetics of ApTOLL in healthy volunteers and found that it has excellent safety and adequate pharmacokinetic profile.

MOLECULAR THERAPY-NUCLEIC ACIDS (2022)

Review Pharmacology & Pharmacy

Strategies for Targeted Delivery of Exosomes to the Brain: Advantages and Challenges

Hojun Choi et al.

Summary: Delivering therapeutics to the central nervous system (CNS) is difficult due to the blood-brain barrier (BBB). Different mechanisms, such as receptor-mediated transcytosis, can be utilized for therapeutic delivery across the BBB. Exosomes, as natural nanoparticles, have the potential to cross the BBB and can be surface-engineered. Surface-modified exosomes have shown enhanced CNS delivery in preclinical studies, but the development of clinically approved exosome therapeutics for CNS diseases requires addressing the challenges of monitoring exosomal delivery to the brain parenchyma in vivo and understanding the mechanisms of BBB crossing.

PHARMACEUTICS (2022)

Review Pharmacology & Pharmacy

Current Strategies to Enhance Delivery of Drugs across the Blood-Brain Barrier

Raluca Ioana Teleanu et al.

Summary: The blood-brain barrier is a significant obstacle to brain medication delivery, but it can be disturbed in certain pathological conditions. This study provides an overview of current brain medication delivery techniques and stimulates readers to explore new ways of delivering medications to the brain. It discusses the construction and function of the blood-brain barrier, as well as controversial questions about nanoparticle and non-nanoparticle options for drug delivery.

PHARMACEUTICS (2022)

Article Biochemistry & Molecular Biology

G-quadruplex-containing oligodeoxynucleotides as DNA topoisomerase I inhibitors

Dawei Li et al.

Summary: It was found that oligodeoxynucleotides (ODNs) containing G-quadruplexes can efficiently inhibit the activity of DNA topoisomerase I. Among them, the parallel propeller-type G-quadruplex is the most effective inhibitor. Combining G-quadruplexes with duplexes to form hybrids can enhance the inhibition efficiency. Moreover, a circular ODN with a G-quadruplex motif and DNA topoisomerase I binding site showed high inhibitory efficiency.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)

Article Chemistry, Applied

Aptamer truncation strategy assisted by molecular docking and sensitive detection of T-2 toxin using SYBR Green I as a signal amplifier

Pengfei Ma et al.

Summary: A novel truncation strategy for aptamers' sequences based on molecular docking was reported for the first time. The truncated aptamers showed increased affinity and were successfully applied in rapid fluorescence detection of T-2 toxin.

FOOD CHEMISTRY (2022)

Article Neurosciences

Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach

Jigyasha Timsina et al.

Summary: This study compared the measurement results of SOMAscan and immunoassay-based methods for five cerebrospinal fluid proteins associated with Alzheimer's disease and neurodegeneration. The results showed that SOMAscan performed as well as immunoassay methods for NfL, Neurogranin, VILIP-1, and sTREM2, but showed weaker correlation for SNAP-25.

JOURNAL OF ALZHEIMERS DISEASE (2022)

Review Immunology

The role of Toll-like receptors and neuroinflammation in Parkinson's disease

Arash Heidari et al.

Summary: Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the loss of dopaminergic neurons and aggregation of alpha-synuclein. Recent studies suggest that neuroinflammation may contribute to the loss of dopaminergic neurons in PD.

JOURNAL OF NEUROINFLAMMATION (2022)

Review Cell Biology

Therapeutic Potential of Different Natural Products for the Treatment of Alzheimer's Disease

Biswajit Chakraborty et al.

Summary: A high incidence of dementia and memory loss are common symptoms of Alzheimer's disease (AD), a neurodegenerative disorder that primarily affects the elderly. Traditional Chinese medicine (TCM) and Indian medicines have been recommended as potential preventive and curative approaches for AD. Neuroinflammation, particularly linked to the deposition of amyloid-beta in the brain, is believed to play a significant role in the pathophysiology of AD. This review focuses on the role of neuroinflammation in neuroprotection and the potential of diverse natural substances and herbal formulations in treating AD. However, further research is needed to fully understand the effectiveness of TCM and Indian Ayurveda in AD treatment.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)

Article Multidisciplinary Sciences

NXP031 prevents dopaminergic neuronal loss and oxidative damage in the AAV-WT-alpha-synuclein mouse model of Parkinson's disease

Min Kyung Song et al.

Summary: Parkinson's disease (PD) is a neurodegenerative disease characterized by alpha-synuclein aggregation. Vitamin C and ascorbic acid have been found to prevent the progression of PD. A new compound, NXP031, consisting of Aptamin C and Vitamin C, has shown neuroprotective effects against PD by alleviating oxidative stress.

PLOS ONE (2022)

Editorial Material Multidisciplinary Sciences

NEURODEGENERATION Elucidating the causes of neurodegeneration

Gregory A. Petsko et al.

SCIENCE (2022)

Article Engineering, Biomedical

Aptamer engineering exosomes loaded on biomimetic periosteum to promote angiogenesis and bone regeneration by targeting injured nerves via JNK3 MAPK pathway

Yanlin Su et al.

Summary: Repairing critical bone defects is a complex problem in the clinic, and little attention has been paid to repairing nerves in the periosteum to promote bone regeneration. This study successfully constructed a biomimetic periosteum, PPEA, which has the ability to repair damaged nerves and promote vascular and bone regeneration. The PPEA biomimetic periosteum provides a promising method for treating bone defects.

MATERIALS TODAY BIO (2022)

Review Cell Biology

New Insights into Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer's Disease and Its Potential for Therapeutic Intervention

Tiantian Li et al.

Summary: This review highlights new insights into the role of neuroinflammation in the pathogenesis of Alzheimer's disease, including the involvement of biomarkers such as NF-kappa B, NLRP3, TREM2, and cGAS-STING. It also provides an overview of novel treatments based on these biomarkers as potential drug targets.

CELLS (2022)

Review Biochemistry & Molecular Biology

Aptamers as Theragnostic Tools in Prostate Cancer

Carlos David Cruz-Hernandez et al.

Summary: Although some drugs can specifically inhibit the androgen receptor (AR), most prostate cancer (PCa) cases still progress to an androgen-independent stage. To address this issue, new tools based on nucleic acids technology, such as aptamers, have been developed. Aptamers are small oligonucleotides capable of interacting with various targets, including mammalian cells or viruses. Studies have shown that aptamers have potential in the diagnosis and treatment of PCa, but more research is needed to determine their clinical value.

BIOMOLECULES (2022)

Article Biochemical Research Methods

Transferrin Aptamers Increase the In Vivo Blood-Brain Barrier Targeting of Protein Spherical Nucleic Acids

Caroline D. Kusmierz et al.

Summary: This study demonstrates the successful delivery of exogenous proteins to cells in the brain and central nervous system by functionalizing them with DNA aptamers that bind to transferrin receptors. By utilizing spherical nucleic acid architecture and the appropriate aptamer sequence design, selective and highly targeted protein delivery can be achieved.

BIOCONJUGATE CHEMISTRY (2022)

Review Biochemistry & Molecular Biology

Glial Cell-Mediated Neuroinflammation in Alzheimer's Disease

Nour F. Al-Ghraiybah et al.

Summary: This review provides an overview of recent advances on the role of microglia and astrocytes in neuroinflammation and provides updates on neuroinflammation diagnostic markers and investigational therapeutics currently in clinical trials.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Biotechnology & Applied Microbiology

Application of aptamers in regenerative medicine

Zhaohui Luo et al.

Summary: Regenerative medicine is a discipline that focuses on repairing and regenerating damaged tissues and organs. The emergence of aptamers has injected new vitality into this field and enriched the application elements of tissue engineering technology.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)

Letter Biochemistry & Molecular Biology

Aptamer blocking S-TLR4 interaction selectively inhibits SARS-CoV-2 induced inflammation

Gang Yang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Review Nanoscience & Nanotechnology

Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications

Shuaijian Ni et al.

Summary: Aptamers, with oligonucleotide sequences, have capabilities to bind to specific target molecules and are attracting great attention in diverse clinical translations. They offer advantages such as prolonged storage life and feasibility of chemical modifications for enhancing stability.

ACS APPLIED MATERIALS & INTERFACES (2021)

Article Nanoscience & Nanotechnology

Aptamer Generated by Cell-SELEX for Specific Targeting of Human Glioma Cells

Ningqin Lin et al.

Summary: Gliomas, the most common primary brain tumors, have poor prognosis and survival rates despite advancements in surgical and radio-chemotherapy technologies. The cell-SELEX technology has been used to develop the S6-1b aptamer, which can distinguish molecular differences between glioma cells and human astrocytes, showing potential for diagnostic and therapeutic applications in malignant gliomas.

ACS APPLIED MATERIALS & INTERFACES (2021)

Article Chemistry, Multidisciplinary

Brain-targeted delivery of obidoxime, using aptamer-modified liposomes, for detoxification of organophosphorus compounds

Yadan Zhang et al.

Summary: The study developed transferrin receptor aptamer-functionalized liposomes (Apt-LP) to deliver AChE reactivator across the blood-brain barrier, showing promising results in treating organophosphorus poisoning by improving drug transport efficiency to the brain.

JOURNAL OF CONTROLLED RELEASE (2021)

Review Biochemistry & Molecular Biology

Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities

Marlene F. Schmidt et al.

Summary: Neurodegenerative diseases are characterized by progressive nervous system damage, such as the selective loss of vulnerable neurons, leading to motor symptoms and cognitive decline. The primary risk factor for these diseases is aging, which results in reduced proteasomal degradation and autophagy, leading to the accumulation of neurotoxic protein aggregates. Ubiquitin plays a critical role in both degradation pathways and non-degradative signaling, implicating it as a potential target for new drugs to treat neurodegenerative diseases.

CELL DEATH AND DIFFERENTIATION (2021)

Article Chemistry, Analytical

An enzyme linked aptamer photoelectrochemical biosensor for Tau-381 protein using AuNPs/MoSe2 as sensing material

Xu Hun et al.

Summary: An in situ enzyme catalysis generating electron donor photoelectrochemical biosensor has been developed for Tau-381 protein detection, with a wide detection range and low limit of detection. This versatile sensing protocol can be easily adapted to detect various targets.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2021)

Article Medicine, Research & Experimental

Novel DEK-Targeting Aptamer Delivered by a Hydrogel Microneedle Attenuates Collagen-Induced Arthritis

Jian Cao et al.

Summary: In this study, DTA was modified to enhance stability and transdermal delivery, effectively inhibiting inflammatory responses and joint damage in rheumatoid arthritis.

MOLECULAR PHARMACEUTICS (2021)

Review Clinical Neurology

Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?

Fangda Leng et al.

Summary: Microglial activation and neuroinflammation play important roles in Alzheimer's disease, affecting disease progression and pathologies. Current research focuses on the interplay between neuroinflammation and amyloid and tau pathologies, with a specific interest in modulating microglia as a therapeutic strategy for AD.

NATURE REVIEWS NEUROLOGY (2021)

Article Neurosciences

Neuroprotective effect of NXP031 in the MPTP-induced Parkinson's disease model

Min Kyung Song et al.

Summary: This study investigated the neuroprotective effects of NXP031 in a MPTP-induced PD model, and found that NXP031 could reduce the loss of dopaminergic neurons, improve motor impairment, increase plasma ascorbic acid levels, and inhibit neuroinflammation. These findings suggest that NXP031 may be a potential therapeutic intervention for PD.

NEUROSCIENCE LETTERS (2021)

Article Chemistry, Multidisciplinary

Aptamer Blocking Strategy Inhibits SARS-CoV-2 Virus Infection

Miao Sun et al.

Summary: The research strategy focused on blocking SARS-CoV-2 infection through aptamer selection, identifying and applying the high-affinity aptamer CoV2-6, further engineered into the circular bivalent aptamer cb-CoV2-6C3 to enhance stability and inhibition efficacy.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Review Biochemistry & Molecular Biology

Deciphering the Role of Nanoparticle-based Treatment for Parkinson's Disease

Md Marufur Rahman Moni et al.

Summary: Parkinson's disease is a progressive neurodegenerative disorder with increasing occurrence. Conventional treatment has side-effects and low bioavailability. Nanotechnology shows great promise in improving treatment efficacy and reducing side-effects for PD patients.

CURRENT DRUG METABOLISM (2021)

Article Pharmacology & Pharmacy

TLR4 and AT1R mediate blood-brain barrier disruption, neuroinflammation, and autonomic dysfunction in spontaneously hypertensive rats

Francesca E. Mowry et al.

Summary: The study demonstrates that inhibiting TLR4 and AT1R in hypertensive rats can restore neuroinflammation, blood-brain barrier disruption, and autonomic dysfunction, suggesting a potential therapeutic approach for hypertension.

PHARMACOLOGICAL RESEARCH (2021)

Article Chemistry, Analytical

Recent Advances in Aptasensor for Cytokine Detection: A Review

Jinmyeong Kim et al.

Summary: Cytokines are proteins secreted by immune cells that play crucial roles in cell signaling and cell life processes. Monitoring cytokine secretion in vivo is important for medical and biological research.

SENSORS (2021)

Article Pharmacology & Pharmacy

Minocycline promotes functional recovery in ischemic stroke by modulating microglia polarization through STAT1/STAT6 pathways

Yunnan Lu et al.

Summary: The study found that minocycline can promote microglial phenotype shift, reduce brain infarct volume, protect neurons from injury, and improve neurological functional recovery after AIS.

BIOCHEMICAL PHARMACOLOGY (2021)

Review Medicine, Research & Experimental

Delivery of oligonucleotide-based therapeutics: challenges and opportunities

Suzan M. Hammond et al.

Summary: The field of nucleic acid-based therapeutics has seen rapid development in recent years, with the main challenge being delivery to target tissues. The adoption of delivery technologies, such as conjugates or nanoparticles, has been a game changer for many therapeutic indications.

EMBO MOLECULAR MEDICINE (2021)

Review Biochemistry & Molecular Biology

Senescent Microglia: The Key to the Ageing Brain?

Eleanor K. Greenwood et al.

Summary: Microglia, as long-lived cells, have been relatively understudied for their role in the ageing process, making it challenging to reliably identify aged microglia without unified markers. Investigating their role in brain homeostasis, especially in iron storage and metabolism, may hold the key to addressing this issue.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Cell Biology

Inflammatory Cascade in Alzheimer's Disease Pathogenesis: A Review of Experimental Findings

Jade de Oliveira et al.

Summary: Alzheimer's disease is the leading cause of dementia worldwide, with the amyloid cascade hypothesis being the most recognized explanation for AD pathology. The mechanisms underlying late onset AD are not completely clear, with BBB disruption playing an essential role in neuroinflammation and AD development. Systemic inflammation triggered by conditions like metabolic diseases or infections may contribute to the neurodegeneration observed in AD.

CELLS (2021)

Review Cell Biology

Exosomes, a New Star for Targeted Delivery

Huizhi Chen et al.

Summary: Exosomes are cell-secreted nanoparticles that can serve as carriers for targeted drug/gene delivery, but the current challenge lies in the insufficient targeting ability and efficacy. Various approaches have been applied to engineer exosomes for higher selectivity and effectiveness.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Clinical Neurology

Microglia-Derived Interleukin 23: A Crucial Cytokine in Alzheimer's Disease?

Louisa Nitsch et al.

Summary: Neuronal cell death, amyloid beta plaque formation, and neurofibrillary tangles are characteristics of Alzheimer's disease, while the involvement of inflammatory processes like microglia and astrocyte activation is crucial in its pathogenesis. Cytokines play an essential role in the immune response of AD. Recent studies have shown the role of interleukin 23 and its p40 subunit in the pathogenesis of AD and have demonstrated potential therapeutic effects with anti-p40 antibody injections in animal models.

FRONTIERS IN NEUROLOGY (2021)

Review Oncology

Microfluidic Chip-Based Cancer Diagnosis and Prediction of Relapse by Detecting Circulating Tumor Cells and Circulating Cancer Stem Cells

Hyeon-Yeol Cho et al.

Summary: The review highlights the significance of metastasis as the main cause of cancer-related death and discusses recent advances in the detection and analysis of circulating tumor cells and circulating cancer stem cells. The focus is on the design of microfluidic devices with optical sensing tools and strategies for analyzing the differentiation of circulating cancer stem cells.

CANCERS (2021)

Review Cell Biology

Microglial Pruning: Relevance for Synaptic Dysfunction in Multiple Sclerosis and Related Experimental Models

Maria Concetta Geloso et al.

Summary: Microglia can rapidly respond to environmental changes and play a role in shaping neuronal wiring. They regulate the elimination of weaker synapses, actively participating in modulating neuronal function. Synaptic dysfunction may be an early and independent event in the neurodegenerative process associated with diseases like multiple sclerosis.

CELLS (2021)

Review Biochemistry & Molecular Biology

Neuroprotective Herbs for the Management of Alzheimer's Disease

Julie Gregory et al.

Summary: This study systematically reviews recent research on the role of neuroprotective herbs and their bioactive compounds in dementia associated with Alzheimer's disease. Medicinal plants have great potential in preventing and treating cognitive decline related to AD, and they can potentially be used in drug discovery programs to identify safe and effective small molecules for AD.

BIOMOLECULES (2021)

Review Allergy

Secondary immunodeficiencies An overview

Karen S. Tuano et al.

Summary: Secondary immunodeficiencies have various causes, including malnutrition, metabolic disorders, medication use, chronic infections, malignancies, and more. Immune responses may be weaker in neonates and the elderly. Clinicians should consider secondary immunodeficiencies in patients with recurrent infections and abnormal immunologic evaluation.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Circular L-RNA aptamer promotes target recognition and controls gene activity

Danyang Ji et al.

Summary: In this study, a simple and robust strategy was developed to generate the first circular L-RNA aptamer, cycL-Apt.4-1c, which demonstrated substantial enhancement in binding affinity and selectivity toward its target. The novel applications of circular L-RNA aptamer in controlling RNA-protein interaction, and gene activity were also notably reported. This approach and findings will be applicable to any L-RNA aptamers and open up a new avenue for diverse applications.

NUCLEIC ACIDS RESEARCH (2021)

Article Multidisciplinary Sciences

Microglial morphology in Alzheimer's disease and after Aβ immunotherapy

Diana K. Franco-Bocanegra et al.

Summary: The study found that reactive/amoeboid microglia are the most common type in the aged human brain, Alzheimer's disease does not affect the number of microglia but decreases ramified microglia, and immunotherapy can increase ramified microglia.

SCIENTIFIC REPORTS (2021)

Review Biotechnology & Applied Microbiology

Advances in aptamer screening and aptasensors' detection of heavy metal ions

Wenfei Guo et al.

Summary: This paper reviews the seriousness of heavy metal pollution and the application of aptasensors in detecting heavy metal ions. It focuses on the methods for selecting aptamers with high specificity and high affinity, as well as the construction methods and research progress of aptamers based on sensors. Finally, the challenges and future opportunities of aptasensors in detecting heavy metal ions are discussed.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Article Medicine, Research & Experimental

Age-associated changes in microglia and astrocytes ameliorate blood-brain barrier dysfunction

Jie Pan et al.

Summary: Research has found that BBB permeability to peripheral cells is significantly enhanced in aged mice, with microglia showing marked alterations in the negative regulation of protein phosphorylation and phagocytic vesicles, and astrocytes exhibiting elevated enzyme or peptidase-inhibitor activity in BBB function recovery.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Article Chemistry, Multidisciplinary

Laser Scribing Fabrication of Graphitic Carbon Biosensors for Label-Free Detection of Interleukin-6

Pei Shee Tan et al.

Summary: Interleukin-6 is a crucial cytokine in inflammatory processes, and a new electrochemical immunosensor platform based on graphitic carbon electrodes has been developed for rapid, low-cost, and sensitive detection.

NANOMATERIALS (2021)

Review Clinical Neurology

Immunotherapies for Neurodegenerative Diseases

Ibrahim Mortada et al.

Summary: Current treatments for neurodegenerative diseases mainly focus on symptomatic relief without addressing the root cause of the disease. Immunotherapy has shown potential in managing disease progression by harnessing the immune system to fight misfolded proteins. Research is ongoing to evaluate the use of immunotherapy in targeting neuroinflammation-induced neurodegeneration.

FRONTIERS IN NEUROLOGY (2021)

Review Cell Biology

B Cells in Neuroinflammation: New Perspectives and Mechanistic Insights

Julie J. Ahn et al.

Summary: In recent years, the role of B cells in neurological disorders has been greatly expanded, highlighting their importance in neuroinflammation. B cells not only contribute to inflammatory diseases through peripheral immune mechanisms, but also through central nervous system mechanisms. Emerging evidence suggests that aberrant B cell populations may play a role in neuroinflammatory processes, emphasizing the potential for B cell-directed therapies in neurological disorders.

CELLS (2021)

Review Biochemistry & Molecular Biology

Uptake mechanisms of cell-internalizing nucleic acid aptamers for applications as pharmacological agents

Samira Husen Alamudi et al.

Summary: Nucleic acid aptamers, also known as chemical antibodies, show promise as targeted therapeutic and delivery agents due to unique advantages over antibodies. Most aptamers can be internalized by cells and enter cells directly, which is important for their potential as pharmacological agents. Understanding selection methods, cellular uptake pathways, and intracellular fates of aptamers is crucial for their applications in medicine.

RSC MEDICINAL CHEMISTRY (2021)

Review Immunology

Neuromodulation by the immune system: a focus on cytokines

Andrea Francesca Salvador et al.

Summary: Interactions between the immune system and the nervous system play a crucial role in shaping host behavior and nervous system function. These interactions may have evolved to maximize an organism's ability to respond to environmental threats. The immune system relays information to the nervous system through cytokine signaling, and the brain may be hardwired to process information from the immune system in a specific way.

NATURE REVIEWS IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

Therapeutic Aptamers: Evolving to Find their Clinical Niche

Shahid M. Nimjee et al.

CURRENT MEDICINAL CHEMISTRY (2020)

Review Biochemistry & Molecular Biology

Therapeutic applications of AS1411 aptamer, an update review

Rezvan Yazdian-Robati et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)

Review Biochemistry & Molecular Biology

Aptamer-Based Targeted Drug Delivery Systems: Current Potential and Challenges

Fen He et al.

CURRENT MEDICINAL CHEMISTRY (2020)

Article Chemistry, Multidisciplinary

Enhanced in Vivo Blood-Brain Barrier Penetration by Circular Tau-Transferrin Receptor Bifunctional Aptamer for Tauopathy Therapy

Xiaowei Li et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)

Review Clinical Neurology

Advances in oral immunomodulating therapies in relapsing multiple sclerosis

Tobias Derfuss et al.

LANCET NEUROLOGY (2020)

Review Biochemistry & Molecular Biology

Aptamers Chemistry: Chemical Modifications and Conjugation Strategies

Fadwa Odeh et al.

MOLECULES (2020)

Review Neurosciences

Systemic factors as mediators of brain homeostasis, ageing and neurodegeneration

John Pluvinage et al.

NATURE REVIEWS NEUROSCIENCE (2020)

Review Multidisciplinary Sciences

The biology, function, and biomedical applications of exosomes

Raghu Kalluri et al.

SCIENCE (2020)

Review Neurosciences

Inflammatory Role of TLR-MyD88 Signaling in Multiple Sclerosis

Chao Zheng et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)

Review Immunology

Neuro-immune Interactions in the Tissues

Coco Chu et al.

IMMUNITY (2020)

Review Biochemistry & Molecular Biology

Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy

Zhaoying Fu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Neurosciences

Central and peripheral anti-inflammatory effects of acetylcholinesterase inhibitors

Shani Vaknine et al.

NEUROPHARMACOLOGY (2020)

Review Biochemistry & Molecular Biology

Non-Invasive Delivery of Therapeutics into the Brain: The Potential of Aptamers for Targeted Delivery

Bakhtiar Bukari et al.

BIOMEDICINES (2020)

Review Neurosciences

Neuroinflammation Treatment via Targeted Delivery of Nanoparticles

Susana R. Cerqueira et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2020)

Review Immunology

Role of Toll Like Receptor 4 in Alzheimer's Disease

Maria Calvo-Rodriguez et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Pharmacology & Pharmacy

Therapeutic Interventions into Innate Immune Diseases by Means of Aptamers

Farzana Yasmeen et al.

PHARMACEUTICS (2020)

Review Biochemistry & Molecular Biology

Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy

Zhaoying Fu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Neurosciences

Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes

Hyuk Sung Kwon et al.

TRANSLATIONAL NEURODEGENERATION (2020)

Review Neurosciences

A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity

Hossam Kadry et al.

FLUIDS AND BARRIERS OF THE CNS (2020)

Article Clinical Neurology

Anti-inflammatories in Alzheimer's disease-potential therapy or spurious correlate?

Jack Rivers-Auty et al.

BRAIN COMMUNICATIONS (2020)

Review Biochemistry & Molecular Biology

Neuroinflammation Mechanisms and Phytotherapeutic Intervention: A Systematic Review

Navrinder Kaur et al.

ACS CHEMICAL NEUROSCIENCE (2020)

Review Medicine, Research & Experimental

Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer's disease, Parkinson's disease

Sean Hong Tan et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Review Immunology

The benefits of neuroinflammation for the repair of the injured central nervous system

Heather Y. F. Yong et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2019)

Review Pharmacology & Pharmacy

An exploration of aptamer internalization mechanisms and their applications in drug delivery

Lin-Yan Wan et al.

EXPERT OPINION ON DRUG DELIVERY (2019)

Article Multidisciplinary Sciences

Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution

Takahiro Masuda et al.

NATURE (2019)

Article Biochemistry & Molecular Biology

Analyzing Secondary Structure Patterns in DNA Aptamers Identified via CompELS

Richard Sullivan et al.

MOLECULES (2019)

Review Biochemistry & Molecular Biology

The Evolving Role of CD8+CD28- Immunosenescent T Cells in Cancer Immunology

Wei X. Huff et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Immunology

Toll-like receptors in the pathogenesis of neuroinflammation

V Kumar

JOURNAL OF NEUROIMMUNOLOGY (2019)

Editorial Material Clinical Neurology

Neuroinflammation - a common thread in neurological disorders

Nils Erik Gilhus et al.

NATURE REVIEWS NEUROLOGY (2019)

Editorial Material Multidisciplinary Sciences

Targeting microglia in brain disorders

Josef Priller et al.

SCIENCE (2019)

Article Medicine, Research & Experimental

Exosomal DNA Aptamer Targeting α-Synuclein Aggregates Reduced Neuropathological Deficits in a Mouse Parkinson's Disease Model

Xiaoxi Ren et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2019)

Review Immunology

A General Introduction to Glucocorticoid Biology

Steven Timmermans et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Pharmacology & Pharmacy

Heat-Shock Proteins in Neuroinflammation

Brigitta Dukay et al.

FRONTIERS IN PHARMACOLOGY (2019)

Review Pharmacology & Pharmacy

Neuroinflammation as a Common Feature of Neurodegenerative Disorders

Leonardo Guzman-Martinez et al.

FRONTIERS IN PHARMACOLOGY (2019)

Review Biochemistry & Molecular Biology

Inside the Black Box: What Makes SELEX Better?

Natalia Komarova et al.

MOLECULES (2019)

Review Biochemistry & Molecular Biology

Microglia in Central Nervous System Inflammation and Multiple Sclerosis Pathology

Sofie Voet et al.

TRENDS IN MOLECULAR MEDICINE (2019)

Review Biochemistry & Molecular Biology

Thermodynamic study of aptamers binding to their target proteins

Taiichi Sakamoto et al.

BIOCHIMIE (2018)

Review Pharmacology & Pharmacy

Selective drug delivery approaches to lesioned brain through blood brain barrier disruption

Zahraa S. Al-Ahmady

EXPERT OPINION ON DRUG DELIVERY (2018)

Review Immunology

Inflammation in CNS neurodegenerative diseases

Jodie Stephenson et al.

IMMUNOLOGY (2018)

Review Cell Biology

Mechanisms of clathrin-mediated endocytosis

Marko Kaksonen et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)

Review Clinical Neurology

Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Melanie D. Sweeney et al.

NATURE REVIEWS NEUROLOGY (2018)

Article Geriatrics & Gerontology

Doxycycline counteracts neuroinflammation restoring memory in Alzheimer's disease mouse models

Claudia Balducci et al.

NEUROBIOLOGY OF AGING (2018)

Review Biochemistry & Molecular Biology

Emerging Paradigm of Intracellular Targeting of G Protein-Coupled Receptors

Madhu Chaturvedi et al.

TRENDS IN BIOCHEMICAL SCIENCES (2018)

Article Geriatrics & Gerontology

NSAID Exposure and Risk of Alzheimer's Disease: An Updated Meta-Analysis From Cohort Studies

Caixia Zhang et al.

FRONTIERS IN AGING NEUROSCIENCE (2018)

Review Pharmacology & Pharmacy

Anti-neuroinflammatory Potential of Natural Products in Attenuation of Alzheimer's Disease

Bushra Shal et al.

FRONTIERS IN PHARMACOLOGY (2018)

Article Medicine, Research & Experimental

Novel DNA Aptamers for Parkinson's Disease Treatment Inhibit alpha-Synuclein Aggregation and Facilitate its Degradation

Yuan Zheng et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2018)

Article Medicine, Research & Experimental

A Synthetic Cross-Species CD200R1 Agonist Suppresses Inflammatory Immune Responses In Vivo

Aaron Prodeus et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2018)

Review Pharmacology & Pharmacy

Aptamer-based targeted therapy

Guizhi Zhu et al.

ADVANCED DRUG DELIVERY REVIEWS (2018)

Review Chemistry, Multidisciplinary

Overcoming the Blood-Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases

Denzil Furtado et al.

ADVANCED MATERIALS (2018)

Review Biochemistry & Molecular Biology

SELEX methods on the road to protein targeting with nucleic acid aptamers

Payam Bayat et al.

BIOCHIMIE (2018)

Review Neurosciences

Microglia Response During Parkinson's Disease: Alpha-Synuclein Intervention

Sara A. Ferreira et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2018)

Review Immunology

Damage-Associated Molecular Patterns in Inflammatory Diseases

Jong Seong Roh et al.

IMMUNE NETWORK (2018)

Review Cell Biology

Neuroprotective Mechanisms of Resveratrol in Alzheimer's Disease: Role of SIRT1

Bruno Alexandre Quadros Gomes et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)

Review Neurosciences

Role of Microglia TLRs in Neurodegeneration

Bernd L. Fiebich et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2018)

Review Pediatrics

Possible strategies to cross the blood-brain barrier

Cinzia M. Bellettato et al.

ITALIAN JOURNAL OF PEDIATRICS (2018)

Article Biochemistry & Molecular Biology

Necroptosis in microglia contributes to neuroinflammation and retinal degeneration through TLR4 activation

Zijing Huang et al.

CELL DEATH AND DIFFERENTIATION (2018)

Review Cell Biology

Aptamers Against Pro- and Anti-Inflammatory Cytokines: A Review

Maryam Boshtam et al.

INFLAMMATION (2017)

Article Neurosciences

Neuroinflammation pathways: a general review

Tara Shabab et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2017)

Review Neurosciences

Inflammatory Response in the CNS: Friend or Foe?

Marta Sochocka et al.

MOLECULAR NEUROBIOLOGY (2017)

Review Biotechnology & Applied Microbiology

Aptamers as targeted therapeutics: current potential and challenges

Jiehua Zhou et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

Review Immunology

Reactive Astrocytes: Production, Function, and Therapeutic Potential

Shane A. Liddelow et al.

IMMUNITY (2017)

Review Biochemistry & Molecular Biology

Natalizumab in Multiple Sclerosis: Long-Term Management

Marinella Clerico et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Review Biochemistry & Molecular Biology

Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes

Shuaijian Ni et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Medicine, Research & Experimental

Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides

Chunsong Yu et al.

MOLECULAR PHARMACEUTICS (2017)

Article Biochemistry & Molecular Biology

Rapid Complexation of Aptamers by Their Specific Antidotes

Heidi Stoll et al.

MOLECULES (2017)

Review Neurosciences

Selective neuronal vulnerability in Parkinson disease

D. James Surmeier et al.

NATURE REVIEWS NEUROSCIENCE (2017)

Review Neurosciences

Neuroimmunology of Traumatic Brain Injury: Time for a ParadigmShift

Yasir N. Jassam et al.

NEURON (2017)

Article Multidisciplinary Sciences

DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis

Nirit Mor-Vaknin et al.

NATURE COMMUNICATIONS (2017)

Article Cell Biology

The Lifespan and Turnover of Microglia in the Human Brain

Pedro Reu et al.

CELL REPORTS (2017)

Article Multidisciplinary Sciences

Assessment of Variability in the SOMAscan Assay

Julian Candia et al.

SCIENTIFIC REPORTS (2017)

Review Immunology

Cytokine networks in neuroinflammation

Burkhard Becher et al.

NATURE REVIEWS IMMUNOLOGY (2017)

Article Clinical Neurology

Molecular-based diagnosis of multiple sclerosis and its progressive stage

Christopher Barbour et al.

ANNALS OF NEUROLOGY (2017)

Review Chemistry, Multidisciplinary

Amyloid beta: structure, biology and structure-based therapeutic development

Guo-fang Chen et al.

ACTA PHARMACOLOGICA SINICA (2017)

Review Medicine, Research & Experimental

Delivery is key: lessons learnt from developing splice-switching antisense therapies

Caroline Godfrey et al.

EMBO MOLECULAR MEDICINE (2017)

Review Neurosciences

Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases

Yu Tang et al.

MOLECULAR NEUROBIOLOGY (2016)

Review Chemistry, Analytical

Aptamers in analytics

Muslum Ilgu et al.

ANALYST (2016)

Review Pharmacology & Pharmacy

Long-term side effects of glucocorticoids

Merih Oray et al.

EXPERT OPINION ON DRUG SAFETY (2016)

Article Biochemistry & Molecular Biology

Neuroinflammation: the devil is in the details

Damon J. DiSabato et al.

JOURNAL OF NEUROCHEMISTRY (2016)

Article Immunology

Brain trauma elicits non-canonical macrophage activation states

Charles C. Kim et al.

JOURNAL OF NEUROINFLAMMATION (2016)

Review Clinical Neurology

Cytokine Therapies in Neurological Disease

Shila Azodi et al.

NEUROTHERAPEUTICS (2016)

Article Multidisciplinary Sciences

Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models

Michael J. D. Daniels et al.

NATURE COMMUNICATIONS (2016)

Article Medicine, Research & Experimental

A Novel PD-L1-targeting Antagonistic DNA Aptamer With Antitumor Effects

Wei-Yun Lai et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2016)

Article Multidisciplinary Sciences

Bioactivity of 2′-deoxyinosine-incorporated aptamer AS1411

Xinmeng Fan et al.

SCIENTIFIC REPORTS (2016)

Review Biochemistry & Molecular Biology

Development of Cell-SELEX Technology and Its Application in Cancer Diagnosis and Therapy

Man Chen et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Review Biochemical Research Methods

Aptamer-Drug Conjugates

Guizhi Zhu et al.

BIOCONJUGATE CHEMISTRY (2015)

Review Neurosciences

RNA Structures as Mediators of Neurological Diseases and as Drug Targets

Viachaslau Bernat et al.

NEURON (2015)

Article Clinical Neurology

Neuroinflammation: Ways in Which the Immune System Affects the Brain

Richard M. Ransohoff et al.

NEUROTHERAPEUTICS (2015)

Article Multidisciplinary Sciences

Inhibition of BACE1 Activity by a DNA Aptamer in an Alzheimer's Disease Cell Model

Huiyu Liang et al.

PLOS ONE (2015)

Review Biochemistry & Molecular Biology

Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease

Mark D. Turner et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)

Review Nanoscience & Nanotechnology

Current approaches to enhance CNS delivery of drugs across the brain barriers

Cui-Tao Lu et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)

Review Neurosciences

Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease

Zhiyou Cai et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2014)

Article Clinical Neurology

Stage-Dependent Nigral Neuronal Loss in Incidental Lewy Body and Parkinson's Disease

Anke A. Dijkstra et al.

MOVEMENT DISORDERS (2014)

Article Medicine, Research & Experimental

Agonistic CD200R1 DNA Aptamers Are Potent Immunosuppressants That Prolong Allogeneic Skin Graft Survival

Aaron Prodeus et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2014)

Review Clinical Neurology

The epigenetics of multiple sclerosis and other related disorders

Peter J. van den Elsen et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2014)

Article Biochemistry & Molecular Biology

A Short DNA Aptamer That Recognizes TNFα and Blocks Its Activity in Vitro

Erik W. Orava et al.

ACS CHEMICAL BIOLOGY (2013)

Article Clinical Neurology

Brain injury biomarkers are not dependent on -amyloid in normal elderly

David S. Knopman et al.

ANNALS OF NEUROLOGY (2013)

Review Oncology

The role of Gliadel wafers in the treatment of high-grade gliomas

Amade Bregy et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2013)

Article Biochemical Research Methods

In vitro selection of a DNA aptamer targeted against Shigella dysenteriae

Nuo Duan et al.

JOURNAL OF MICROBIOLOGICAL METHODS (2013)

Review Multidisciplinary Sciences

Microglia: Scapegoat, Saboteur, or Something Else?

Adriano Aguzzi et al.

SCIENCE (2013)

Article Cell Biology

Minocycline selectively inhibits M1 polarization of microglia

K. Kobayashi et al.

CELL DEATH & DISEASE (2013)

Article Medicine, Research & Experimental

In vivo SELEX for Identification of Brain-penetrating Aptamers

Congsheng Cheng et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2013)

Article Biochemical Research Methods

Single-molecule atomic force microscopy on live cells compares aptamer and antibody rupture forces

Meghan B. O'Donoghue et al.

ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2012)

Article Chemistry, Analytical

Selection of DNA Aptamers That Recognize α-Synuclein Oligomers Using a Competitive Screening Method

Kaori Tsukakoshi et al.

ANALYTICAL CHEMISTRY (2012)

Review Clinical Neurology

Gene expression profiling in human neurodegenerative disease

Johnathan Cooper-Knock et al.

NATURE REVIEWS NEUROLOGY (2012)

Review Clinical Neurology

Examining the mechanisms that link beta-amyloid and alpha-synuclein pathologies

Samuel E. Marsh et al.

ALZHEIMERS RESEARCH & THERAPY (2012)

Article Medicine, Research & Experimental

An RNA Alternative to Human Transferrin: A New Tool for Targeting Human Cells

Samantha E. Wilner et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2012)

Review Biochemistry & Molecular Biology

Cell-SELEX Technology

Shoji Ohuchi

BIORESEARCH OPEN ACCESS (2012)

Article Multidisciplinary Sciences

Bioavailability of resveratrol

Thomas Walle

RESVERATROL AND HEALTH (2011)

Review Cell Biology

The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights

Agnes E. Coutinho et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)

Review Cell Biology

Molecular mechanism and physiological functions of clathrin-mediated endocytosis

Harvey T. McMahon et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)

Review Biochemistry & Molecular Biology

Mechanisms Underlying Inflammation in Neurodegeneration

Christopher K. Glass et al.

Review Immunology

Inflammation in neurodegenerative diseases

Sandra Amor et al.

IMMUNOLOGY (2010)

Review Nanoscience & Nanotechnology

The emerging field of RNA nanotechnology

Peixuan Guo

NATURE NANOTECHNOLOGY (2010)

Review Neurosciences

Structure and function of the blood-brain barrier

N. Joan Abbott et al.

NEUROBIOLOGY OF DISEASE (2010)

Article Multidisciplinary Sciences

Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages

Florent Ginhoux et al.

SCIENCE (2010)

Review Chemistry, Medicinal

Non-Steroidal Anti-Inflammatory Drugs and Brain Inflammation: Effects on Microglial Functions

Maria Antonietta Ajmone-Cat et al.

PHARMACEUTICALS (2010)

Review Pharmacology & Pharmacy

Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists

Joerg Vollmer et al.

ADVANCED DRUG DELIVERY REVIEWS (2009)

Review Biochemistry & Molecular Biology

Mechanisms of Endocytosis

Gary J. Doherty et al.

ANNUAL REVIEW OF BIOCHEMISTRY (2009)

Review Pharmacology & Pharmacy

An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease

Bruno P. Imbimbo

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)

Review Clinical Neurology

Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?

Erin E. Longbrake et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)

Article Medicine, Research & Experimental

Multivalent 4-1BB binding aptamers costimulate CD8(+) T cells and inhibit tumor growth in mice

James O. McNamara et al.

JOURNAL OF CLINICAL INVESTIGATION (2008)

Article Biochemistry & Molecular Biology

Exploring TAR-RNA aptamer loop-loop interaction by X-ray crystallography, UV spectroscopy and surface plasmon resonance

Isabelle Lebars et al.

NUCLEIC ACIDS RESEARCH (2008)

Article Multidisciplinary Sciences

Aptamer-based endocytosis of a lysosomal enzyme

Chi-hong B. Chen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Review Cell Biology

Glucocorticoids in the control of neuroinflammation

Denise Tischner et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)

Article Clinical Neurology

Perispinal etanercept for treatment of Alzheimer's disease

Edward Tobinick

CURRENT ALZHEIMER RESEARCH (2007)

Article Cell Biology

The LPS receptor, CD14 in experimental autoimmune encephalomyelitis and multiple sclerosis

S Walter et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2006)

Article Chemistry, Multidisciplinary

Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain

J Kreuter

JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2004)

Article Chemistry, Multidisciplinary

Pharmacokinetics and biodistribution of novel aptamer compositions

JM Healy et al.

PHARMACEUTICAL RESEARCH (2004)

Article Clinical Neurology

Broad expression of Toll-like receptors in the human central nervous system

M Bsibsi et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)

Review Multidisciplinary Sciences

Oxidants, oxidative stress and the biology of ageing

T Finkel et al.

NATURE (2000)

Article Biochemistry & Molecular Biology

Tetracycline affects abnormal properties of synthetic PrP peptides and PrPSc in vitro

F Tagliavini et al.

JOURNAL OF MOLECULAR BIOLOGY (2000)